{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:02:03Z","timestamp":1790996523513,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-77038-w","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T15:00:47Z","timestamp":1730300447000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Bacteriophages targeting Enterococcus faecalis enhance the therapeutic efficacy of levodopa in an MPTP-induced Parkinson\u2019s disease mouse model with E. faecalis gut colonization"],"prefix":"10.1038","volume":"14","author":[{"given":"Joon-Pyo","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sooan","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Hyeon","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung-chul","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-gon","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoongeun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bombi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mijung","family":"Yeom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hi-Joon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang\u2011Hwan","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jongki","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae-Hyun","family":"Hahm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,30]]},"reference":[{"key":"77038_CR1","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.chom.2017.03.010","volume":"21","author":"C Tropini","year":"2017","unstructured":"Tropini, C., Earle, K. A., Huang, K. C. & Sonnenburg, J. L. The gut microbiome: Connecting spatial organization to function. Cell Host Microbe 21, 433\u2013442 (2017).","journal-title":"Cell Host Microbe"},{"key":"77038_CR2","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1038\/518S3a","volume":"518","author":"M Velasquez-Manoff","year":"2015","unstructured":"Velasquez-Manoff, M. The peace\u00adkeepers amid the trillions of microbes that live in the intestines, scientists have found a few species that seem to play a key role in keeping us healthy. Nature 518, S4-11 (2015).","journal-title":"Nature"},{"key":"77038_CR3","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.3390\/microorganisms10122436","volume":"10","author":"IM Andrioaie","year":"2022","unstructured":"Andrioaie, I. M. et al. The role of the gut microbiome in psychiatric disorders. Microorganisms 10, 2436 (2022).","journal-title":"Microorganisms"},{"key":"77038_CR4","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/nature05414","volume":"444","author":"PJ Turnbaugh","year":"2006","unstructured":"Turnbaugh, P. J. et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027\u20131031 (2006).","journal-title":"Nature"},{"key":"77038_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-022-03296-9","volume":"20","author":"P Gebrayel","year":"2022","unstructured":"Gebrayel, P. et al. Microbiota medicine: Towards clinical revolution. J. Transl. Med. 20, 1\u201320 (2022).","journal-title":"J. Transl. Med."},{"key":"77038_CR6","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrmicro.2016.17","volume":"14","author":"P Spanogiannopoulos","year":"2016","unstructured":"Spanogiannopoulos, P., Bess, E. N., Carmody, R. N. & Turnbaugh, P. J. The microbial pharmacists within us: A metagenomic view of xenobiotic metabolism. Nat. Rev. Microbiol. 14, 273\u2013287 (2016).","journal-title":"Nat. Rev. Microbiol."},{"key":"77038_CR7","doi-asserted-by":"publisher","first-page":"eaau6323","DOI":"10.1126\/science.aau6323","volume":"364","author":"VM Rekdal","year":"2019","unstructured":"Rekdal, V. M., Bess, E. N., Bisanz, J. E., Turnbaugh, P. J. & Balskus, E. P. Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism. Science 364, eaau6323 (2019).","journal-title":"Science"},{"key":"77038_CR8","doi-asserted-by":"publisher","first-page":"233","DOI":"10.4161\/gmic.27915","volume":"5","author":"HJ Haiser","year":"2014","unstructured":"Haiser, H. J., Seim, K. L., Balskus, E. P. & Turnbaugh, P. J. Mechanistic insight into digoxin inactivation by Eggerthella lenta augments our understanding of its pharmacokinetics. Gut Microbes 5, 233\u2013238 (2014).","journal-title":"Gut Microbes"},{"key":"77038_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","volume":"359","author":"V Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan, V. et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359, 97\u2013103 (2018).","journal-title":"Science"},{"key":"77038_CR10","doi-asserted-by":"publisher","first-page":"1046910","DOI":"10.3389\/fneur.2023.1046910","volume":"14","author":"Z Zhong","year":"2023","unstructured":"Zhong, Z., Ye, M. & Yan, F. A review of studies on gut microbiota and levodopa metabolism. Front. Neurol. 14, 1046910 (2023).","journal-title":"Front. Neurol."},{"key":"77038_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2015.01543","volume":"6","author":"MP Francino","year":"2016","unstructured":"Francino, M. P. Antibiotics and the human gut microbiome: Dysbioses and accumulation of resistances. Front. Microbiol. 6, 1\u201311 (2016).","journal-title":"Front. Microbiol."},{"key":"77038_CR12","doi-asserted-by":"publisher","first-page":"e2443","DOI":"10.1212\/WNL.0000000000201204","volume":"99","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. Association between microbial tyrosine decarboxylase gene and levodopa responsiveness in patients with Parkinson disease. Neurology 99, e2443\u2013e2453 (2022).","journal-title":"Neurology"},{"key":"77038_CR13","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41467-019-08294-y","volume":"10","author":"SP van Kessel","year":"2019","unstructured":"van Kessel, S. P. et al. Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson\u2019s disease. Nat. Commun. 10, 310 (2019).","journal-title":"Nat. Commun."},{"key":"77038_CR14","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/S0306-4522(96)00545-3","volume":"77","author":"NA Tatton","year":"1997","unstructured":"Tatton, N. A. & Kish, S. J. In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining. Neuroscience 77, 1037\u20131048 (1997).","journal-title":"Neuroscience"},{"key":"77038_CR15","volume-title":"Molecular Cloning: A Laboratory Manual","author":"J Sambrook","year":"1989","unstructured":"Sambrook, J., Fritsch, E. F. & Maniatis, T. Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Laboratory Press, 1989)."},{"key":"77038_CR16","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/jam.12844","volume":"119","author":"M Yeom","year":"2015","unstructured":"Yeom, M. et al. Oral administration of Lactobacillus casei variety rhamnosus partially alleviates TMA-induced atopic dermatitis in mice through improving intestinal microbiota. J. Appl. Microbiol. 119, 560\u2013570 (2015).","journal-title":"J. Appl. Microbiol."},{"key":"77038_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.4068\/cmj.2017.53.1.56","volume":"53","author":"MR Arabestani","year":"2017","unstructured":"Arabestani, M. R., Nasaj, M. & Mousavi, S. M. Correlation between infective factors and antibiotic resistance in Enterococci clinical isolates in west of Iran. Chonnam Med. J. 53, 56\u201363 (2017).","journal-title":"Chonnam Med. J."},{"key":"77038_CR18","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41531-021-00260-0","volume":"7","author":"SP van Kessel","year":"2021","unstructured":"van Kessel, S. P., Auvinen, P., Scheperjans, F. & El Aidy, S. Gut bacterial tyrosine decarboxylase associates with clinical variables in a longitudinal cohort study of Parkinsons disease. NPJ Parkinsons Dis. 7, 115 (2021).","journal-title":"NPJ Parkinsons Dis."},{"key":"77038_CR19","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.medmal.2008.06.023","volume":"38","author":"M Kutateladze","year":"2008","unstructured":"Kutateladze, M. & Adamia, R. Phage therapy experience at the Eliava Institute. Med. Mal. Infect. 38, 426\u2013430 (2008).","journal-title":"Med. Mal. Infect."},{"key":"77038_CR20","first-page":"86","volume":"6","author":"A Paule","year":"2018","unstructured":"Paule, A., Frezza, D. & Edeas, M. Microbiota and phage therapy: Future challenges in medicine. Med. Sci. 6, 86 (2018).","journal-title":"Med. Sci."},{"key":"77038_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2019.00513","volume":"10","author":"N Principi","year":"2019","unstructured":"Principi, N., Silvestri, E. & Esposito, S. Advantages and limitations of bacteriophages for the treatment of bacterial infections. Front. Pharmacol. 10, 1\u20139 (2019).","journal-title":"Front. Pharmacol."},{"key":"77038_CR22","first-page":"1","volume":"363","author":"P Speck","year":"2015","unstructured":"Speck, P. & Smithyman, A. Safety and efficacy of phage therapy via the intravenous route. FEMS Microbiol. Lett. 363, 1\u20135 (2015).","journal-title":"FEMS Microbiol. Lett."},{"key":"77038_CR23","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1001\/jamaoto.2019.1191","volume":"145","author":"ML Ooi","year":"2019","unstructured":"Ooi, M. L. et al. Safety and tolerability of bacteriophage therapy for chronic rhinosinusitis due to staphylococcus aureus. JAMA Otolaryngol-Head Neck Surg. 145, 723\u2013729 (2019).","journal-title":"JAMA Otolaryngol-Head Neck Surg."},{"key":"77038_CR24","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41564-019-0634-z","volume":"5","author":"A Petrovic Fabijan","year":"2020","unstructured":"Petrovic Fabijan, A. et al. Safety of bacteriophage therapy in severe Staphylococcus aureus infection. Nat. Microbiol. 5, 465\u2013472 (2020).","journal-title":"Nat. Microbiol."},{"key":"77038_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2018.01701","volume":"9","author":"W Phothichaisri","year":"2018","unstructured":"Phothichaisri, W. et al. Characterization of bacteriophages infecting clinical isolates of clostridium difficile. Front. Microbiol. 9, 1\u201313 (2018).","journal-title":"Front. Microbiol."},{"key":"77038_CR26","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.cell.2018.08.041","volume":"174","author":"N Zmora","year":"2018","unstructured":"Zmora, N. et al. Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features. Cell 174, 1388-1405.e21 (2018).","journal-title":"Cell"},{"key":"77038_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcimb.2021.609722","volume":"11","author":"S Han","year":"2021","unstructured":"Han, S. et al. Probiotic gastrointestinal transit and colonization after oral administration: A long journey. Front. Cell Infect. Microbiol. 11, 1\u201312 (2021).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"77038_CR28","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1007\/s00284-019-01706-8","volume":"76","author":"C Li","year":"2019","unstructured":"Li, C. et al. Adhesion and colonization of the probiotic Lactobacillus rhamnosus labeled by Dsred2 in mouse gut. Curr. Microbiol. 76, 896\u2013903 (2019).","journal-title":"Curr. Microbiol."},{"key":"77038_CR29","doi-asserted-by":"publisher","first-page":"10219","DOI":"10.1007\/s00253-018-9378-6","volume":"102","author":"H-D Bao","year":"2018","unstructured":"Bao, H.-D. et al. Alterations in the diversity and composition of mice gut microbiota by lytic or temperate gut phage treatment. Appl. Microbiol. Biotechnol. 102, 10219\u201310230 (2018).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"77038_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2018.e00644","volume":"4","author":"T Ceylani","year":"2018","unstructured":"Ceylani, T., Jakubowska-Do\u011fru, E., Gurbanov, R., Teker, H. T. & Gozen, A. G. The effects of repeated antibiotic administration to juvenile BALB\/c mice on the microbiota status and animal behavior at the adult age. Heliyon 4, e00644 (2018).","journal-title":"Heliyon"},{"key":"77038_CR31","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/s41385-018-0042-3","volume":"11","author":"HM Jang","year":"2018","unstructured":"Jang, H. M., Lee, H. J., Jang, S. E., Han, M. J. & Kim, D. H. Evidence for interplay among antibacterial-induced gut microbiota disturbance, neuro-inflammation, and anxiety in mice. Mucosal Immunol. 11, 1386\u20131397 (2018).","journal-title":"Mucosal Immunol."},{"key":"77038_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2020.564271","volume":"11","author":"KE Lee","year":"2020","unstructured":"Lee, K. E., Kim, J. K. & Kim, D. H. Orally administered antibiotics vancomycin and ampicillin cause cognitive impairment with gut dysbiosis in mice with transient global forebrain ischemia. Front. Microbiol. 11, 1\u201314 (2020).","journal-title":"Front. Microbiol."},{"key":"77038_CR33","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1002\/med.21572","volume":"39","author":"K D\u0105browska","year":"2019","unstructured":"D\u0105browska, K. Phage therapy: What factors shape phage pharmacokinetics and bioavailability? Systematic and critical review. Med. Res. Rev. 39, 2000\u20132025 (2019).","journal-title":"Med. Res. Rev."},{"key":"77038_CR34","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/s41591-019-0437-z","volume":"25","author":"RM Dedrick","year":"2019","unstructured":"Dedrick, R. M. et al. Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus. Nat. Med. 25, 730\u2013733 (2019).","journal-title":"Nat. Med."},{"key":"77038_CR35","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00954-17","volume":"61","author":"RT Schooley","year":"2017","unstructured":"Schooley, R. T. et al. Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection. Antimicrob. Agents Chemother. 61, e00954 (2017).","journal-title":"Antimicrob. Agents Chemother."},{"key":"77038_CR36","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/mds.870110106","volume":"11","author":"EJ Pappert","year":"1996","unstructured":"Pappert, E. J. et al. Levodopa stability in solution: Time course, environmental effects, and practical recommendations for clinical use. Mov. Disord. 11, 24\u201326 (1996).","journal-title":"Mov. Disord."},{"issue":"Suppl 2","key":"77038_CR37","doi-asserted-by":"publisher","first-page":"S253","DOI":"10.1007\/s00415-010-5728-8","volume":"257","author":"M Contin","year":"2010","unstructured":"Contin, M. & Martinelli, P. Pharmacokinetics of levodopa. J. Neurol. 257(Suppl 2), S253\u2013S261 (2010).","journal-title":"J. Neurol."},{"key":"77038_CR38","first-page":"223","volume":"3","author":"A Nordberg","year":"1985","unstructured":"Nordberg, A., Nyberg, P. & Windblad, B. Topographic distribution of choline acetyltransferase activity and muscarinic and nicotinic receptors in Parkinson brains. Neurochem Pathol. 3, 223\u2013236 (1985).","journal-title":"Neurochem Pathol."},{"key":"77038_CR39","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s004010100372","volume":"102","author":"PM Mattila","year":"2001","unstructured":"Mattila, P. M. et al. Choline acetytransferase activity and striatal dopamine receptors in Parkinson\u2019s disease in relation to cognitive impairment. Acta Neuropathol. 102, 160\u2013166 (2001).","journal-title":"Acta Neuropathol."},{"key":"77038_CR40","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1159\/000115172","volume":"19","author":"O Bugiani","year":"1980","unstructured":"Bugiani, O. et al. Loss of striatal neurons in Parkinson\u2019s disease: A cytometric study. Eur Neurol. 19, 339\u2013344 (1980).","journal-title":"Eur Neurol."},{"key":"77038_CR41","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.neuron.2019.06.013","volume":"103","author":"JW McKinley","year":"2019","unstructured":"McKinley, J. W. et al. Dopamine deficiency reduces striatal cholinergic interneuron function in models of Parkinson\u2019s disease. Neuron 103, 1056-1072.e6 (2019).","journal-title":"Neuron"},{"key":"77038_CR42","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1523\/JNEUROSCI.2888-13.2014","volume":"34","author":"L Won","year":"2014","unstructured":"Won, L., Ding, Y., Singh, P. & Kang, U. J. Striatal cholinergic cell ablation attenuates L-DOPA induced dyskinesia in Parkinsonian mice. J. Neurosci. 34, 3090\u20133094 (2014).","journal-title":"J. Neurosci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77038-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77038-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77038-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T15:19:45Z","timestamp":1730301585000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77038-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,30]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["77038"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-77038-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,30]]},"assertion":[{"value":"4 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26146"}}